- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Transitional Care Planning
Total 145019 results
-
Centre Hospitalier Universitaire de NīmesSaint-Louis Hospital, Paris, France; Institut Paoli-Calmettes; Center Eugene... and other collaboratorsRecruitingCancer | Urothelial CarcinomaFrance
-
Leonard ApplemanSanofi-SynthelaboCompletedMetastatic Transitional Cell Cancer of the Urothelial TractUnited States
-
Boston Children's HospitalCompletedCar Seat Transition for At-risk InfantsUnited States
-
Trillium Health PartnersCentre for Aging and Brain Health InnovationUnknownCommunication | Care TransitionCanada
-
Seth LernerAstraZeneca; Cytogen CorporationCompletedUrinary Bladder NeoplasmsUnited States, Italy
-
RemeGen Co., Ltd.RecruitingUrothelial Carcinoma | HER2-expressingChina
-
China Medical University, TaiwanRecruitingMedicine, Chinese TraditionalTaiwan
-
Eli Lilly and CompanyCompletedUrologic Neoplasms | Metastases, NeoplasmUnited States
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Recruiting
-
Shanxi Province Cancer HospitalCancer Institute and Hospital, Chinese Academy of Medical SciencesRecruiting
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.RecruitingUrothelial CarcinomaUnited States
-
Centre Hospitalier Universitaire de NīmesInstitut Bergonié; Institut de cancérologie Strasbourg Europe; Centre Antoine... and other collaboratorsRecruiting
-
Changhai HospitalRenJi Hospital; West China Hospital; Tongji Hospital; Qilu Hospital of Shandong... and other collaboratorsRecruitingUrothelial CarcinomaChina
-
Janssen Research & Development, LLCActive, not recruitingUrothelial CarcinomaFrance, United States, Korea, Republic of, Belgium, Taiwan, Turkey, Russian Federation, Spain, Italy, United Kingdom, Brazil, Belarus, Poland
-
AstraZenecaCompletedUrothelial CarcinomaUnited States
-
Chang Gung Memorial HospitalActive, not recruitingUrothelial CarcinomaTaiwan
-
RemeGen Co., Ltd.CompletedUrothelial CarcinomaChina
-
Shanghai Zhongshan HospitalFudan University; Shanghai Jiao Tong University School of MedicineCompletedUrothelial Carcinoma
-
RemeGen Co., Ltd.Completed
-
The Netherlands Cancer Institute4SC AGActive, not recruitingUrothelial CarcinomaNetherlands
-
Matthew GalskyAstraZenecaActive, not recruitingUrothelial CarcinomaUnited States
-
Hoosier Cancer Research NetworkBristol-Myers SquibbCompletedUrothelial CarcinomaUnited States
-
Genentech, Inc.Approved for marketing
-
Bristol-Myers SquibbCompletedUrothelial CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteEndo PharmaceuticalsCompletedUrothelial CarcinomaUnited States
-
Rambam Health Care CampusCompleted
-
National Taiwan University HospitalUnknownUrothelial CarcinomaTaiwan
-
China Medical University HospitalUnknown
-
China Medical University HospitalUnknown
-
National Cancer Institute (NCI)CompletedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Adenocarcinoma of the Bladder | Distal... and other conditionsUnited States
-
Holbaek SygehusRegion Sjælland; Danish Institute for Public HealthCompletedFrailty | Readmission | Primary Care | TransitionDenmark
-
Federation of Italian Cooperative Oncology GroupsRecruitingCarcinoma, UrothelialItaly
-
Tianjin Medical University Second HospitalRecruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingCarcinoma, Transitional Cell | HER-2 Gene AmplificationChina
-
Novartis PharmaceuticalsCompletedUrothelial CancerUnited States, Spain, Taiwan, Germany, Canada, United Kingdom, Italy, Austria
-
RemeGen Co., Ltd.CompletedAdvanced Cancer | Urothelial CarcinomaChina
-
Indiana UniversityCompletedAdolescent Behavior | TransitionUnited States
-
Queen Mary University of LondonNot yet recruitingTransitional Cell Carcinoma | Bladder Cancer
-
Queen Mary University of LondonHoffmann-La RocheUnknownBladder CancerUnited Kingdom, France, Spain, Netherlands
-
Merck Sharp & Dohme LLCCompleted
-
National Cancer Institute (NCI)CompletedCarcinoma, Transitional Cell | Bladder NeoplasmsUnited States
-
European Organisation for Research and Treatment...National Cancer Institute (NCI); Medical Research Council; NCIC Clinical Trials... and other collaboratorsCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerFrance, Spain, Canada, United States, Denmark, Poland, Belgium, Germany, Netherlands, Italy, United Kingdom, Austria, Australia, Hungary, Slovakia, Israel
-
European Organisation for Research and Treatment...CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerNetherlands, Spain, United Kingdom, Poland, Belgium, Denmark, Hungary, Germany, Israel, Italy, Austria
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited States
-
Istanbul Medipol University HospitalCompletedPeriodontitis | Root Planing | Amoxicillin | Metronidazole | OfloxacinTurkey
-
University of WashingtonNational Institute of Mental Health (NIMH); Kenyatta National HospitalActive, not recruitingPlanning the mPACT Trial - mHealth Strategies for the Pediatric to Adult HIV Care Transition (mPACT)Transition From Pediatric to Adult HIV CareKenya
-
Mabwell (Shanghai) Bioscience Co., Ltd.Not yet recruitingAdvanced Urothelial CarcinomaChina
-
First Affiliated Hospital of Zhejiang UniversityNot yet recruiting
-
Centre Francois BaclessePfizerRecruiting
-
National Taiwan University HospitalRecruiting